Tetravalent agonists of erythropoietin receptor
CA3328565A1Pending Publication Date: 2025-11-20EPOK THERAPEUTICS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CA3328565
- Authority / Receiving Office
- CA · CA
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-05-13
- Filing Date
- 2025-05-13
- Publication Date
- 2025-11-20
Abstract
It forms an object of the present invention a tetravalent antibody construct capable of selectively binding with high affinity to human EPOR, acting as a hEPOR agonist. It forms a further object said antibody for use in the treatment of kidney diseases and anemias.
Need to check novelty before this filing date? Find Prior Art
